Dangerous levels of immune inflammation and complications of cardiovascular surgery
Last scientific data authentically demonstrate that the immune inflammation plays a significant role in shaping of the cardiovascular disease. The search for effective ways to identify and stabilize dangerous levels of immune inflammation is an important aspect in the prevention of intra-and postoperative bleeding and thrombotic and repair complications. We had performed a prospective study of 227 patients undergoing various cardiovascular operations from 2002 to 2012. We had included only patients who had clinical and laboratory signs of significant immune inflammation of the cardiovascular bed in our study. All these patients had received a personal version of the immunotherapy. After a re-evaluation of the immune status all patients underwent elective surgery. Our data demonstrate the effectiveness of efforts to correct the dangerous levels of immune inflammation, it help to improve the safety of operations and to reduce the number of complications.